CJC1295 + GHRP-6 is a growth hormone (GH) secretagogue blend designed to gently stimulate your body’s own GH release rather than replacing it from the outside.

It combines two peptides that work on different control points of the GH system:

CJC1295 – a long-acting analogue of growth hormone–releasing hormone (GHRH). It acts on the pituitary gland to encourage a more youthful, rhythmic pattern of GH release.

GHRP-6 – a ghrelin-receptor agonist (a type of growth hormone–releasing peptide).

It switches on an additional GH pathway and helps trigger stronger GH pulses, while also interacting with appetite and metabolic signalling.

Used together, CJC1295 sets the baseline GH rhythm, while GHRP-6 adds extra GH pulses, aiming to mimic a more youthful pattern of hormone release. The GH pulses help keep IGF-1 (a key repair and recovery hormone) gently supported over time. This can support: Improved protein synthesis, deeper restorative sleep and night-time repair, better recovery from training and busy schedules, Body composition goals (supporting lean muscle and fat metabolism) and healthy-ageing programs focused on tissue repair, vitality and performance

CJC12195+GHRP6  is not an FDA‑approved medicine and is not intended to diagnose, treat, cure or prevent any disease. Always follow the advice of your prescribing practitioner.

When used as directed and alongside a healthy lifestyle, clients commonly use CJC1295 + GHRP-6 to help support:

Deep, restorative sleep

GH pulses are naturally tied to deep sleep. By supporting this system, many people report better sleep depth, more refreshing nights and improved next-day energy.

Recovery from training and daily stress

GH and IGF-1 are key players in tissue repair. This blend is often used to help the body bounce back more effectively from exercise, physical work and busy life demands.

Lean muscle support and strength progression

With adequate protein and a solid resistance-training program, CJC1295 + GHRP-6 can be used to support lean mass, progression in the gym and training consistency.

Fat metabolism & body composition

GH secretagogues are commonly used in body-recomposition protocols to support fat mobilisation and body-shape change while helping to protect muscle.

Healthy-ageing and overall vitality

By nudging natural GH rhythms rather than overriding them, this protocol is often included in broader healthy-ageing programs aimed at supporting tissue quality, body composition and long-term resilience.

*Individual results vary. This peptide blend works best as part of a complete plan created with your healthcare provider and is not a substitute for healthy nutrition, movement, sleep or medical care.

Active Ingredients

CJC1295 – 2,000 mcg/mL

GHRP-6 – 2,000 mcg/mL

Excipients

Sterile diluent (e.g., bacteriostatic saline) and standard compounding excipients as specified by the partner pharmacy (may include buffering agents and preservatives).

Presentation

Injectable

CJC1295 + GHRP-6 2000 mcg/2000 mcg per mL – 5 mL multidose vial

(Total content per vial: 10,000 mcg CJC1295 + 10,000 mcg GHRP-6 at 2,000 mcg/mL)

Cream & Forte Cream

Standard Cream: 200/200 mcg per mL, (100ml)

Forte Cream: 400/400 mcg per mL, (100ml)

Protocol & Standard Dosing

Injectable – CJC1295 + GHRP-6 (2000/2000 mcg/mL, 5 mL vial)

Body-weight–based standard dosing

< 70 kg: 0.10 mL SC nightly on an empty stomach, 5 days per week (5/7)

> 70 kg: 0.15 mL SC nightly on an empty stomach, 5 days per week (5/7)

Potential dose increase (if tolerated and indicated)

May increase to:

• 0.10 mL twice daily in smaller individuals
• 0.15 mL twice daily in larger individuals

Only under prescriber guidance and if well tolerated.

Timing & administration

Night time dosing is preferred – Inject last thing before bed, at least 2 hours after the last meal. 

If morning dosing is required – inject upon waking at least 30 minutes before eating.

Route: 

Subcutaneous injection into fatty tissue (e.g. lower abdomen, outer thigh) using an insulin syringe, as instructed by your healthcare professional.

Use 5 days on / 2 days off per week (e.g. Mon–Fri on, weekend off), unless advised otherwise.

Cream & Forte Cream – 200/200 mcg & 400/400 mcg per mL

Standard topical dosing

Dose: 1 mL (2 pumps)

Application site:

Transdermal to inner forearms (or as directed)

Timing:

Nightly or AM post-shower on an empty stomach

Frequency: 5 days per week (5/7)

Potential dose increase

May increase to twice daily application (e.g. morning and night) if tolerated and clinically indicated, under prescriber guidance.

How to use (topical)

1. Apply to clean, dry skin of the inner forearms.
2. Rub it thoroughly and allow it to dry before dressing.
3. Wash hands after application and avoid contact with others’ skin at the application site until fully absorbed.

Side Effects, Reactions & Medical Contraindications

Use is generally not recommended in:

• Known allergy or hypersensitivity to CJC1295, GHRP-6 or any vial/cream component
• Pregnancy or breastfeeding (insufficient safety data)
• Active malignancy or history of cancer unless cleared by a specialist (due to theoretical effects on growth pathways)
• Uncontrolled diabetes, significant cardiovascular disease, severe kidney or liver disease without specialist supervision
• Individuals with a history of intracranial tumours or pituitary disorders unless managed by an appropriate specialist
• Individuals subject to professional or federation anti-doping testing (WADA / similar), as GH secretagogues are generally prohibited in tested sport

Common Side Effects and Adverse Reactions – Often mild and transient where they occur:

Injectable

• Injection-site redness, itching, mild swelling or small bruises
• Temporary water retention or puffiness
• Increased hunger (more common with GHRP-6), vivid dreams or changes in sleep pattern
• Headache, light-headedness or fatigue, especially during the first weeks

Topical Cream / Forte

• Local skin irritation at application site: redness, itching, dryness or mild burning
• Occasional transient flushing or warmth
• Rarely, mild systemic effects similar to low-dose injectable use (e.g. vivid dreams, mild headache)
• If symptoms are persistent, uncomfortable or worrying, contact your healthcare provider to discuss dose adjustment, timing changes or whether to pause treatment.

Reactions Requiring Medical Attention

• Stop treatment and contact a healthcare provider (or emergency services if severe) if experiencing:
• Signs of a serious allergic reaction:
• Widespread rash or hives
• Facial or tongue swelling
• Difficulty breathing
• Severe or persistent headache, visual changes, chest pain or shortness of breath
• Marked swelling of ankles/hands, rapid unexplained weight gain, or significant changes in blood pressure
• Any new or worsening symptom that feels serious, unusual or concerning

Safety Note: Long‑term data is limited. Use should always be monitored by a qualified clinician, with regular reviews and ongoing medical supervision.  Informed consent is essential.